Search Market Research Report

Discover Our Latest Reports
Discover Our Featured Reports
Discover Top Selling Reports

Telepathology Service Market Size, Share Global Analysis Report, , 2022 – 2028

report img

Telepathology Service Market By System (Hybrid, Static and Dynamic), By Implementation (Research, Education, Diagnosis and Other), and By End User (Diagnostic Centres and Pathology Clinics, Hospitals, Academic Institutes, Research Organisations, Pharmaceutical, and Biotechnology Firms): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2022 – 2028

Industry Insights

[207+ Pages Report] According to Facts and Factors, the Telepathology Service Market was worth around 645.37 (USD million) in 2021 and is predicted to grow around 1,788 (USD million) by 2028, with a compound annual growth rate (CAGR) of around 12.15% between 2022 and 2028. The report analyses the Telepathology Service Market's drivers and restraints, as well as the impact they have on-demand throughout the projection period. In addition, the report examines global opportunities in the Telepathology Service Market.

logoMarket Overview

The electronic transmission of high-quality pathological data over a long distance using telecommunications technologies is described as telepathology. It paves the way for the transport of high-resolution image-rich pathological data between locations for research, diagnostic, and educational needs. This technology's applications include an expert opinion on emergency services, referral cases, quality assurance, educational training, diagnosis, conferences, and gatherings. Telepathology is a relatively new technology that makes use of developments in communications to contact patients in remote locations and offer the best diagnostic inference to a distance healthcare practitioner.

Telepathology is a technology-driven medical industry segment. It's a cutting-edge digital imaging and telecommunications technology that's revolutionizing the way healthcare is delivered around the world.

Telepathology Service Market

To know more about this report | Request Free Sample Copy

logo Growth Drivers

Cost reduction is a key factor for the evolution of any technology that delivers cost-effectiveness and worldwide reaches to the entire market in today's economy. Accurate pathological assessment, speedy diagnosis, early treatment, and the provision of high-quality healthcare are only a few of the major elements driving telepathology's global market demand.

Furthermore, the prevalence of cancer, the increased workload of healthcare providers, and developments in laboratory diagnostic tests all contribute to the global growth of the global telepathology service market.

In order to notice and acknowledge discrepancies, there must be equivalence between the telepathology system and the pathologist's typical style of practice. The characteristics and advantages of telepathology systems vary from one organization to the next. The telecommunication technologies, scanning software, and backup systems used by each organization differ. The key to establishing a presence in the telepathology service industry is to have a setup with a pathologist-centric system architecture that is based on provider requirements and built to suit end-user criteria.

logoReport Scope

Report Attribute

Details

Market Size in 2021

USD 645.37 Million

Projected Market Size in 2028

USD 1,788 Million

CAGR Growth Rate

12.15% CAGR

Base Year

2021

Forecast Years

2022-2028

Key Market Players

Leica Biosystems Nussloch GmbH, Canada Health Infoway, GE Healthcare, AMD Global Telemedicine, Inc., TeleConsult Europe (TCE), SRL Diagnostics, Universal Service Administrative Company, Telemedicine Clinic, Apollo Telehealth, and University Health Network., among others

Key Segment

By System, By Implementation, By End-User, and By Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

logoRegional Landscape

North America owns the biggest market share in the global telepathology service market because of the availability of well-equipped infrastructure and better use of modern technologies. Massive investments in furthering technological innovation have fuelled the region's market expansion. Deep Lens, an Ohio-based digital pathology firm, received early funding of 3.2 USD million in 2018 for the development of an AI-based platform that will allow pathologists to diagnose cancer disease in patients more reliably and speedily. The platform, which employs powerful AI capabilities, enables the immediate execution of certain diagnostic tests. Due to the greater adoption of advanced technologies in China, India, and South Korea, the Asia Pacific area is also predicted to increase the most throughout the forecast period. As a result, industry participants' large-scale investments are impacting the regional market growth.

logoCompetitive Landscape

The global telepathology service market's primary tactics are product releases, mergers & acquisitions, joint ventures, and geographic expansion. The following are some of the market's most important companies:

  • Leica Biosystems Nussloch GmbH
  • Canada Health Infoway
  • GE Healthcare
  • AMD Global Telemedicine Inc.
  • TeleConsult Europe (TCE)
  • SRL Diagnostics
  • Universal Service Administrative Company
  • Telemedicine Clinic
  • Apollo Telehealth
  • University Health Network.

Global Telepathology Service Market is segmented as follows:

logoBy System Segment Analysis

  • Hybrid
  • Static
  • Dynamic

logoBy Implementation Segment Analysis

  • Research
  • Education
  • Diagnosis
  • Other

logoBy End-user Segment Analysis

  • Diagnostic centres
  • Pathology clinics
  • Hospitals
  • Academic institutes
  • Research Organisations
  • Pharmaceutical firms
  • Biotechnology firms

logoBy Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Nordic countries
      • Denmark
      • Finland
      • Iceland
      • Sweden
      • Norway
    • Benelux Reunion
      • Belgium
      • The Netherlands
      • Luxembourg
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • New Zealand
    • Australia
    • South Korea
    • Southeast Asia
      • Indonesia
      • Thailand
      • Malaysia
      • Singapore
      • Rest of Southeast Asia
    • Rest of Southeast Asia
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Kuwait
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Industry Major Market Players

  • Leica Biosystems Nussloch GmbH
  • Canada Health Infoway
  • GE Healthcare
  • AMD Global Telemedicine Inc.
  • TeleConsult Europe (TCE)
  • SRL Diagnostics
  • Universal Service Administrative Company
  • Telemedicine Clinic
  • Apollo Telehealth
  • University Health Network.

Frequently Asked Questions

Accurate pathological assessment, speedy diagnosis, early treatment, and the provision of high-quality healthcare are only a few of the major elements driving telepathology's global market demand.
According to the Facts & Factors, The Telepathology Service Market was worth around 645.37 (USD million) in 2021 and is predicted to grow around 1,788 (USD million) by 2028 with a compound annual growth rate (CAGR) of around 12.15% between 2022 and 2028.
North American owns the biggest market share in the global telepathology service market because of the availability of well-equipped infrastructure and better use of modern technologies.
Some of the market's most important companies are Leica Biosystems Nussloch GmbH, Canada Health Infoway, GE Healthcare, AMD Global Telemedicine, Inc., TeleConsult Europe (TCE), SRL Diagnostics, Universal Service Administrative Company, Telemedicine Clinic, Apollo Telehealth, and University Health Network.